NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/07/2023
Back to search
Official data from USPTO
CR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
03/07/2023
Classification
Registered
Trademark type
Combined
Nice classes
5
Filing date
11/15/2021
Registration date
03/07/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/07/2023
Last transaction
03/07/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Beijing, CN
Examiner
GARCIA, CLAUDIA
Law office
M20
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of an abstract design consisting of circular and curved line shapes depicting the letters "CR".
Holders and representatives
Holders
Corregene Biotechnology Co., Ltd
Representatives
Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological preparations for the treatment of cancer, precancerous lesions, chronic infections, autoimmune diseases, fatty liver, inflammatory bowel disease, cervical neoplasia, viral infections, metabolic diseases, immunodeficiency, osteoarthritis, tumors, thyroid disease, glycometabolism disease, bone metabolic disease, gonad disease, kidney disease, cardiovascular disease, hepatic fibrosis, anemia, inflammation diseases, hepatitis disease, Epstein-Barr (EB) viruses, hormonal diseases, allergic, immune disorder, TORCH infections and immunoglobulin diseases; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Chemical reagents for medical or veterinary purposes; Cultures of microorganisms for medical or veterinary use; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Stem cells for medical purposes; Stem cells for veterinary purposes; Surgical implants comprised of living tissues
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/20/2022
PUBO
PUBLISHED FOR OPPOSITION
12/20/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/30/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/17/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/30/2022
GNRT
NON-FINAL ACTION E-MAILED
08/30/2022
CNRT
NON-FINAL ACTION WRITTEN
08/30/2022
DOCK
ASSIGNED TO EXAMINER
08/25/2022
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
11/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/19/2021
NWAP
NEW APPLICATION ENTERED
11/18/2021
Continuous trademark protection
Get notified about every new filing that threatens CR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.